v3.26.1
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Sep. 11, 2024
Jun. 17, 2024
Mar. 11, 2024
Nov. 03, 2023
Jul. 27, 2023
Jul. 05, 2023
Jan. 31, 2023
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Loss Contingencies [Line Items]                      
Upfront payment             $ 150,000        
Future payment upon meeting milestone             $ 1,000,000        
Payments for research and development     $ 50,000                
Maximum [Member]                      
Loss Contingencies [Line Items]                      
Payment of milestone amount       $ 27,250,000              
Minotaur Agreement [Member]                      
Loss Contingencies [Line Items]                      
License fees               $ 0 $ 0 $ 0 $ 0
ABSI [Member]                      
Loss Contingencies [Line Items]                      
Common stock issued         25,107            
Value of common stock issued         $ 250,000            
Payments for research and development               0 50,000 0 100,000
ABSI [Member] | Maximum [Member]                      
Loss Contingencies [Line Items]                      
ABSI shares issued, shares           $ 8,250,000          
ABSI [Member]                      
Loss Contingencies [Line Items]                      
Net proceeds from offering           $ 10,000,000          
Intract Patent License Agreement (Member)                      
Loss Contingencies [Line Items]                      
Upfront payment $ 400,000     400,000              
License fees               0 0 0 600,000
Milestone fees       $ 150,000             150,000
Avior Patent License Agreement [Member]                      
Loss Contingencies [Line Items]                      
Milestone fees               200,000 0 200,000 200,000
Enkefalos License Agreement [Member]                      
Loss Contingencies [Line Items]                      
Upfront payment   $ 150,000                  
License fees               $ 0 $ 0 $ 0 $ 200,000